Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 4

2(33.3%)

Phase 2

2(33.3%)

6Total

N/A(2)

Phase 4(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04312932Phase 2Completed

Fatty Acid Supplementation in Children With ASD (Study 2)

Role: lead

NCT05191823Not ApplicableEnrolling By Invitation

Omega Tots Long Term Follow-up

Role: lead

NCT03664089Not ApplicableCompleted

Physical Activity Intervention for Gestational Diabetes

Role: lead

NCT03550209Phase 2Completed

Fatty Acid Supplementation in Children With ASD

Role: lead

NCT01576783Phase 4Completed

Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes

Role: lead

NCT01683565Phase 4Completed

Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood

Role: lead

All 6 trials loaded